1-20 of 21
Jason T. Romancik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Sequential CD19-Directed Therapies in Relapsed and Refractory Large B Cell Lymphoma

David A Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Hamuza Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham Wehmeyer, Jason T. Romancik, Behzad Amoozgar, Lori A. Leslie, Loretta J. Nastoupil, Jennifer L Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami J. Maddocks, Sarah C. Rutherford, Brad S. Kahl, Michelle Okwali, Michael Buege, Venkatraman Seshan, Connie Wing-Ching Lee Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2023-182204
Published: 2023
Journal Articles

Exploration of Language As a Barrier to the Assessment and Management of CAR T-Cell Therapy Associated Toxicities

Megan Melody, Narendranath Epperla, Matthew J Cortese, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Jonathon B. Cohen, Geoffrey P. Shouse, Ishan Roy, Stefan K. Barta, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 2407.
https://doi.org/10.1182/blood-2023-183041
Published: 2023
Journal Articles

Immune Reconstitution and Infection Patterns Following CAR T-Cell Therapy in Patients with Aggressive Lymphoma

Megan Melody, Narendranath Epperla, Geoffrey P. Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P Kenkre, Thomas Ollila, Lindsey Fitzgerald, Brian Hess, Kevin A. David, Kaitlin Annunzio, Megan Herr, Rahul S. Bhansali, Elyse I Harris, James A Davis, Oluwatobi Odetola, Adam Yuh Lin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Deborah M. Stephens, Alexey Danilov, Nirav N. Shah, Ishan Roy, Stefan K. Barta, Matthew J Cortese, Pallawi Torka, Jonathon B. Cohen, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2023) 142 (Supplement 1): 1738.
https://doi.org/10.1182/blood-2023-183011
Published: 2023
Journal Articles

Multicenter Study to Assess the Outcomes and Prognosis of Richter's Transformation in the Era of Novel Agents and Cell Therapy

Fateeha Furqan, Katelin Baird, Merve Kacar, Annika S Surapaneni, Ulrich Kemmo Tsafack, Aniko Szabo, Jakub Svoboda, Brian T. Hill, Jason T. Romancik, Nirav N. Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4486.
https://doi.org/10.1182/blood-2023-186703
Published: 2023
Journal Articles

Patterns of Care and Prognostic Modeling Following Follicular Lymphoma Transformation to Aggressive B-Cell Lymphoma: An Analysis from the LEO Consortium

Jonathan R Day, Melissa C. Larson, Carla Casulo, Urshila Durani, Yucai Wang, Dai Chihara, Loretta J. Nastoupil, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Jason T. Romancik, Amy Ayers, Richard Burack, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Brian K. Link
Journal: Blood
Blood (2023) 142 (Supplement 1): 3111.
https://doi.org/10.1182/blood-2023-179650
Published: 2023
Journal Articles

Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers

Emily Ayers, Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Augustus Qualls, Behzad Amoozgar, Brad S. Kahl, John H. Baird, Pavan Challa, Scott F. Huntington, Jennifer Santos, Steven M. Bair, Mayur S. Narkhede, Shuning Li, Zachary AK Frosch, Carrie I Ho, Stephen D Smith, Allison Winter, Daniel J. Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason T. Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana H. Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Debamita Kundu, Mwanasha Hamuza Merrill, Jennifer L Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 312.
https://doi.org/10.1182/blood-2023-174257
Published: 2023
Journal Articles

The Presence of Bulky Disease and/or Very High LDH Defines a High-Risk Subset of IPI 1-2 for Eligibility in Clinical Trials of Newly Diagnosed Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Umar Farooq, Jason T. Romancik, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Dai Chihara, Andrew L. Feldman, Sergei Syrbu, David L Jaye, Elliot Cahn, Thomas M. Habermann, Brian K. Link, James R. Cerhan, Christopher R. Flowers, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4512.
https://doi.org/10.1182/blood-2023-187350
Published: 2023
Journal Articles

Overall Survival Following First and Second Relapse of DLBCL Treated with Therapies Including Autologous Transplant and CAR-T Cells: Results from the Lion Prospective Observational Registry

Greg Kirkpatrick, Jeffrey M. Switchenko, Melissa Kives, Katelin Baird, Kami J. Maddocks, Jason T. Romancik, Deborah M. Stephens, Harsh Shah, Javier Pinilla-Ibarz, Julio C Chavez, Matthew Matasar, Craig A. Portell, Michelle Churchman, Jonathon B. Cohen, Umar Farooq, Brian K. Link
Journal: Blood
Blood (2023) 142 (Supplement 1): 6325.
https://doi.org/10.1182/blood-2023-187198
Published: 2023
Journal Articles

Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis

Arushi Khurana, Raphael Mwangi, Loretta J. Nastoupil, Patrick M. Reagan, Umar Farooq, Jason T. Romancik, Timothy J. McDonnell, Shaun M Riska, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Thomas E. Witzig, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Grzegorz S. Nowakowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 2056–2058.
https://doi.org/10.1182/blood-2022-169433
Published: 2022
Journal Articles

Favorable Overall Survival Following First and Second Relapse of MCL with Availability of Novel Therapies: Results from the Lion Prospective Observational Registry

David A. Bond, Jason T. Romancik, Jeffrey M. Switchenko, Brielle Berkowitz, Jonathan R Day, Umar Farooq, Sabarish Ayyappan, Katelin Baird, Michelle L. Churchman, Andrew M. Evens, Bijal D. Shah, Craig A. Portell, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Deborah M. Stephens
Journal: Blood
Blood (2022) 140 (Supplement 1): 6509–6511.
https://doi.org/10.1182/blood-2022-160306
Published: 2022
Journal Articles

Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions

Ajay Major, Jovian Yu, Navika D. Shukla, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie G Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood
Blood (2022) 140 (Supplement 1): 1328–1331.
https://doi.org/10.1182/blood-2022-157829
Published: 2022
Journal Articles

Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-Cell Lymphomas Treated with Chimeric Antigen Receptor T-Cell (CART) Therapy

Reem Karmali, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon
Journal: Blood
Blood (2022) 140 (Supplement 1): 10955–10957.
https://doi.org/10.1182/blood-2022-160431
Published: 2022
Journal Articles

Real-World Analysis of Cytopenias after Chimeric Antigen Receptor T-Cell Therapy: A Comparison of BCMA and CD19 Based Outcomes

Tony Z. Zhuang, Manali Rupji, Pranav R. Santapuram, Michael Graiser, Jason T. Romancik, Jonathon B. Cohen
Journal: Blood
Blood (2022) 140 (Supplement 1): 12133–12134.
https://doi.org/10.1182/blood-2022-166196
Published: 2022
Journal Articles

Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study

David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Journal: Blood
Blood (2022) 140 (Supplement 1): 787–789.
https://doi.org/10.1182/blood-2022-167620
Published: 2022
Journal Articles

Double Hit/Double Expressor Lymphomas: A Multicenter Analysis of Survival Outcomes with CD19-Directed CAR T-Cell Therapy

Joanna Zurko, Geoffrey Shouse, Pallawi Torka, Tamara K. Moyo, Jason T. Romancik, Imran A. Nizamuddin, Kaitlin Annunzio, Jieqi Liu, Stefan K. Barta, Robert Ferdman, Rahul Bhansali, Jonathon B. Cohen, Sayan Mullick Chowdhury, Nirav N. Shah, Elyse I. Harris, Vaishalee P. Kenkre, McKenzie Sorrell, Brian T. Hess, Deborah M. Stephens, Lindsey A. Fitzgerald, Thomas A. Ollila, Ishan Roy, Shuo Ma, Jane N. Winter, Barbara Pro, Jonathan Moreira, Leo I. Gordon, Alexey V Danilov, Andrew M. Evens, Narendranath Epperla, Reem Karmali
Journal: Blood
Blood (2022) 140 (Supplement 1): 375–377.
https://doi.org/10.1182/blood-2022-163438
Published: 2022
Journal Articles

Consensus Cachexia Criteria Are Independently Linked to Progression Free and Overall Survival in Multi-Site Analysis of Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy

Ishan Roy, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul S. Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Jonathan Moreira, Shuo Ma, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon, Reem Karmali
Journal: Blood
Blood (2022) 140 (Supplement 1): 2416–2418.
https://doi.org/10.1182/blood-2022-163822
Published: 2022
Journal Articles

Practice Patterns Pre-CART for Aggressive B-Cell Lymphomas: Patient Selection and Real World Salvage and Bridging Practices

Imran Nizamuddin, Kevin A. David, Jonathon B. Cohen, Vaishalee P. Kenkre, Geoffrey Shouse, Brian T. Hess, Thomas A. Ollila, Deborah M. Stephens, Sayan Mullick Chowdhury, Robert Ferdman, Kaitlyn O'Shea, Jieqi Liu, Jason T. Romancik, Joanna C. Zurko, Rahul S. Bhansali, Elyse I. Harris, McKenzie Sorrell, Rebecca Masel, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane N. Winter, Barbara Pro, Leo I. Gordon, Alexey V. Danilov, Nirav N. Shah, Stefan K. Barta, Narendranath Epperla, Pallawi Torka, Reem Karmali
Journal: Blood
Blood (2021) 138 (Supplement 1): 532.
https://doi.org/10.1182/blood-2021-147033
Published: 2021
Journal Articles

Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel

Jason T. Romancik, Subir Goyal, James N Gerson, Hatcher J Ballard, Yazeed Sawalha, David A. Bond, Michael Joseph Rogalski, Irl Brian Greenwell, Koen van Besien, Samuel Yamshon, Reem Karmali, Imran Nizamuddin, Pallawi Torka, Victor A. Chow, Mazyar Shadman, Nilanjan Ghosh, Tamara K. Moyo, Timothy S. Fenske, Alexandra Rezazadeh, Natalie S Grover, Kami J. Maddocks, Caron Jacobson, Jonathon B. Cohen
Journal: Blood
Blood (2021) 138 (Supplement 1): 1756.
https://doi.org/10.1182/blood-2021-153277
Published: 2021
Journal Articles

Outcomes of Patients with Relapsed Mantle Cell Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis

Yazeed Sawalha, MD, Subir Goyal, PhD, Jeffrey M. Switchenko, PhD MS, Jason T. Romancik, MD, Manali Kamdar, MD, Irl Brian Greenwell, MD, Brian T. Hess, MD, Krista Isaac, DO,MS, Craig A. Portell, MD, Alex V. Mejia Garcia, MD, Scott R. Goldsmith, MD, Natalie S Grover, MD, Peter A. Riedell, MD, Reem Karmali, MDMSc, Madelyn Burkart, MD, Michael J Buege, PharmD, Othman S. Akhtar, MD, Pallawi Torka, MD, Anita Kumar, MD, Brian T. Hill, MD, Brad S. Kahl, MD, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–6.
https://doi.org/10.1182/blood-2020-138878
Published: 2020
Journal Articles

Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma

Jason T. Romancik, MD, Pamela B. Allen, MD MSc, Edmund K. Waller, PhDMD, Zhengjia Chen, PhD, Kelly Valla, PharmD, Kaylan Dixon, BS, David J. Reagan, Amanda B. Colbert, Cecilia Rosand, PA-C, Alexandra Palmer, NP-C, Christopher Flowers, MDMS, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 39.
https://doi.org/10.1182/blood-2020-141030
Published: 2020